Oripem 1 GM Injection contains Meropenem 1000 mg, a broad-spectrum carbapenem antibiotic indicated for the treatment of severe bacterial infections caused by susceptible strains of microorganisms. Meropenem exerts its bactericidal action by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, thereby disrupting peptidoglycan cross-linking. This results in cell lysis and death of the pathogen. Oripem 1 GM Injection is effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria, including multidrug-resistant strains. It is commonly employed in the management of complicated intra-abdominal infections, bacterial meningitis, skin and soft tissue infections, urinary tract infections, and febrile neutropenia. The drug is administered intravenously, ensuring rapid systemic distribution and optimal therapeutic levels. Dosage and duration of therapy should be tailored according to the severity of infection, patient renal function, and clinical response. Caution is advised in patients with known hypersensitivity to beta-lactam antibiotics. Adverse effects may include gastrointestinal disturbances, hypersensitivity reactions, and transient elevations in liver enzymes. Oripem 1 GM Injection should be used under strict medical supervision to ensure appropriate antimicrobial stewardship and to minimize the development of resistance.